If you are hunting ASX 200 shares to buy, then read on.
That's because listed below are five ASX 200 broker buy ratings from this week.
Here's what is being recommended by brokers:
Image source: Getty Images
Capstone Copper Corp (ASX: CSC)
UBS is positive on this copper miner's shares. It was pleased with the company's solid quarterly performance, which revealed production and costs largely in line with expectations.
According to the note, UBS has retained its buy rating with a reduced price target of $17.50. Based on its current share price of $15.19, this implies potential upside of 15% for investors.
Credit Corp Group Ltd (ASX: CCP)
The team at Morgans is bullish on this debt collector's shares. Following the release of its record FY 2026 results, the broker retained its buy rating with a trimmed price target of $18.25. This implies potential upside of over 35% for investors from current levels.
Morgans notes that "at ~7.7x FY27F PE, the valuation continues to appear undemanding."
Netwealth Group Ltd (ASX: NWL)
Macquarie is recommending Netwealth as an ASX 200 stock to buy ahead of its results release this month.
The broker believes the investment platform provider will deliver a result in line with the market's expectations. It also feels confident about its FY 2027 guidance.
As a result, Macquarie has retained its outperform rating on Netwealth's shares with a slightly improved price target of $32.60. Based on its current share price of $24.91, this implies potential upside of 31% over the next 12 months.
Neuren Pharmaceuticals Ltd (ASX: NEU)
The team at Bell Potter is recommending this biotechnology company's shares to investors this week.
In response to an "impressive" quarterly sales update, the broker has retained its buy rating on Neuren Pharmaceuticals shares with an improved price target of $25.50.
Based on its current share price of $21.56, this implies potential upside of 18% for investors.
Light & Wonder Inc (ASX: LNW)
Bell Potter remains bullish on this gaming technology company. In response to its second quarter update, the broker has retained its buy rating on the ASX 200 stock with a trimmed price target of $183.00. Based on its current share price of $118.08, this implies potential upside of 55% for investors over the next 12 months.
The broker highlights that its analysts "see a resumption in top line growth occurring in 4Q26. We believe LNW offers compelling value at 10x EV/EBIT(A) given growth metrics."
